SEC Form 4 · accession 0001500814-17-000004
Diplomat Pharmacy, Inc. · DPLO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joel Saban
Officer — President
Period of report
Aug 10, 2017
Accepted (ET)
Aug 11, 2017 · 4:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610092
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option to Acquire Common StockF1 | $15.94 | Aug 10, 2017 | A | 200,000 | A | — | Aug 10, 2027 | Common Stock | 200,000 | 200,000 | D |
Explanation of responses
- F1The option will vest in annual increments of 25% of the option grant beginning on the one-year anniversary of the grant date.